The modulation of the PP2A/MAPKs/HIF-1α pathway represents a potential mechanism underlying the beneficial impact of FGF21 on Alzheimer's disease-like pathologies47. This evidence concerns the gene FGF21 and early-onset autosomal dominant Alzheimer disease.